Rural Pharmacy and Prescription Drugs – News
News stories from the past 60 days.
Public Inspection: CMS: Medicare Program: Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
Federal Register
Oct 19, 2026 - Pre-publication notice of a proposed rule that would implement the following sections of the Consolidated Appropriations Act, 2026: 1) section 6219, "Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals;" 2) section 6220, "Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act;" and 3) section 6224, "Modernizing and Ensuring Pharmacy Benefit Manager Accountability." The implementation of Section 6219 would reduce the generic drug copayment from $1 to $0 for full-benefit dual eligible individuals at or below 100% of the Federal Poverty Level, effective for plan years starting January 1, 2028. The implementation of Section 6220, the REAL Health Providers Act, would establish new provider directory accuracy and accountability requirements for Medicare Advantage (MA) organizations beginning in contract year 2028. In addition, CMS has several proposals to implement section 6224, which established requirements related to pharmacy benefit managers (PBMs) and their affiliates specific to the Medicare Part D program. Comments are due by December 15, 2026.
Source: Federal Register
CMS: Global Benchmark for Efficient Drug Pricing (GLOBE) Model
Federal Register
Oct 2, 2026 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) implementing the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biological products reduces costs for Original Medicare fee-for-service (FFS) beneficiaries and the Medicare program while preserving quality of care. This rule also summarizes and responds to comments received on the December 23, 2025, proposed rule, including the potential impact of this model on small rural hospitals. These regulations are effective November 30, 2026.
Source: Federal Register
Sep 30, 2026 - Offers an interview with an Appalachian pharmacy educator discussing access to pharmacies for rural communities. Discusses policy, rural culture, barriers in healthcare access, trust, and rural innovation.
Source: Drug Topics
CMS: Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards
Federal Register
Sep 24, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking public input regarding the establishment of standards for reasonable and relevant pharmacy contract terms and conditions under the Medicare prescription drug benefit as outlined by Section 6223(a) of the Consolidated Appropriations Act, 2026 (P.L. 119-75). Specifically, CMS seeks comments on pharmacy reimbursement and dispensing fees, current contract practices, trends in contract terms and conditions, and pharmacy quality and performance measures, among other things. Comments are due by November 23, 2026.
Source: Federal Register
CMS: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Sep 1, 2026 - Notice from the Centers for Medicare & Medicaid Services
(CMS) seeking comments on the following information
collections: 1) Survey of Retail Prices; 2) Basic Health
Program (BHP) Supporting Regulations; and 3) Solicitation
for Applications for Medicare Prescription Drug Plan 2028
Contracts. Comments are due by November 2, 2026.
Source: Federal Register
Aug 20, 2026 - Highlights a philanthropic program in 9 states to ensure rural hospitals have access to generic drugs during drug shortages. Discusses how the pilot program will offer rural hospitals more consistency in drug availability, potential cost savings, and the goal to offer the program nationally.
Source: The Daily Yonder

